ABSTRACI'. Children with nephropathic cystinosis store 50 to 100 times normal amounts of free cystine in many cells and display negligible lysosomal cystine transport in their leucocytes and cultured fibroblasts. A patient with intermediate (adolescent) cystinosis exhibited a similar deficiency of egress out of fibroblast lysosome-rich granular fractions. Another individual with benign (adult) cystinosis accumulated only 2.85 nmol 112 cystinelmg leucocyte protein, or 20-50% of the amount stored in nephropathic cystinosis leucocytes. His leucocyte granular fractions also displayed substantial residual cystine-carrying capacity, as determined by measurement of lysosomal cystine countertransport. We conclude that the variant forms of cystinosis represent a continuum of lysosomal cystine storage, with the varied clinical presentation depending on the amount of residual cystine-carrying capacity, genetic predispositions, and differential tissue susceptibilities. (Pediatr Res 21: 193-196,1987) Infantile nephropathic cystinosis is a lysosomal storage disorder inherited in an autosomal recessive fashion and characterized by renal Fanconi syndrome in the 1st yr of life with subsequent growth retardation, corneal cystine crystals, and glomerular dysfunction requiring renal transplantation (1) (2) (3) . In many tissues of cystinosis patients, the disulfide amino acid, cystine, accumulates to such high levels within cellular lysosomes that crystals form. The disorder results from impaired transport of cystine out of lysosomes into the cytoplasm (4-7), where it would normally be reduced to the free thiol, cysteine.
Three varieties of cystinosis have been described. The most common is classical nephropathic cystinosis with onset in infancy and inexorable progression to renal failure in the first decade of life (1-3). In contrast, patients with intermediate (adolescent) cystinosis do not manifest kidney disease until after infancy and have a variable rate of progression to renal demise (8-12). Benign (adult) cystinosis patients have no renal disease at all and live normally as adults except for their corneal crystals (13-18). Intermediate and benign variants of cystinosis have been described in fewer than 20 kindreds.
In addition to their milder disease compared with classical infantile cystinosis patients, individuals with cystinosis variants store lesser amounts of cystine within their cells (1, 2, 8, 16 ). We determined whether, like nephropathic cystinosis patients, these individuals had impaired lysosomal cystine transport and, if so, to what extent. Two methods of assessing cystine transport were employed, namely, measurements of cystine egress velocity (5) and lysosomal cystine counter-transport or uptake (7). The techniques were applied to cells from patients with intermediate and benign cystinosis. Patient 2. A 14-yr-old boy was evaluated at age 6 9/~2 yr due to a finding of corneal crystals on routine ophthalmologic examination. Growth was normal, serum creatinine was 0.7 mg/dl, serum electrolytes and urinalysis were normal, bone age was 6-7 yr, and there was no evidence of rickets. Crystals were seen in a bone marrow biopsy but not in a renal biopsy which had been fixed in absolute ethanol. A diagnosis of benign cystinosis was made.
By age 14%2 yr, the patient was 166 cm tall (50%) and weighed 73 kg (90%). Electrolytes were normal, blood urea nitrogen was 15 mg/dl, serum creatinine was 1.0 mg/dl with a creatinine clearance of 8 1 ml/min (lab normal, 60-90 ml/min), urinalysis was normal with urine osmolalities of 410 and 8 15 mOsmol/ liter, undetectable urine protein, and a normal fractional excretion of phosphate (0.20). Bone age was 14 yr. Slit lamp examination revealed crystals in the anterior two-thirds of the corneal stroma. Retinal and skin pigmentation was normal.
METHODS
The fibroblasts of patient 1 (GM379) and his father (GM906) were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ) and grown in minimal essential medium supplemented with 10% fetal calf serum, glutamine, and nonessential amino acids (19) . Polymorphonuclear leucocytes from patient 2 were prepared by dextran sedimentation of heparinized blood and hypotonic lysis of erythrocytes.
Cystine egress from leucocyte (4, 5) or fibroblast (19) granular fractions was measured as described. Whole cells were exposed to 0.5 mM (fibroblasts) or 1.0 mM (leucocytes) cystine dimethylester, washed in Hanks' balanced salt solution for 30 min at 37" C, and submitted to 30 psi nitrogen cavitation for 10 min (fibroblasts) or to limited sonication for 10 s (leucocytes). The cell homogenate was centrifuged at 1000 X g for 5 min and the supernatant centrifuged at 17000 x g for 10 min. The pellet, a lysosome-rich granular fraction, was placed in 0.25 M sucrose (0.4 M for fibroblasts), 10 mM Hepes, pH 7.0, at 37" C. At zero 194 GAHL AND TIETZE supernatant per min, corrected for lysosomal rupture by the percentage of soluble (supernatant) hexosaminidase activity, gave a measure of lysosomal cystine egress (5).
Cystine counter-transport, not demonstrable in fibroblast granular fractions (1 9), was measured in polymorphonuclear leucocytes as described (7). Granular fractions, loaded with nonradioactive cystine, were exposed to tracer amounts (7.5 pM) of [3H]cystine (Amersham, Arlington Heights, IL, final specific radioactivity 875 mCi/mmol) in sucrose-Hepes buffer containing 1 mM N-ethyl-maleimide. After 0 and 60 min at 37" C, 1.0-ml aliquots were removed and centrifuged at 17000 x g for 10 min. The resulting pellets were washed thoroughly of residual ['HI cystine, once by resuspension with a pasteur pipet, and once by resuspension using a glass pestle. The final washed pellets were suspended in 1.0 ml of water, sonicated, and assayed for radioactivity and hexosaminidase activity.
[3H]Cystine uptake after 60 min in the cystine-loaded granular fractions was compared with that in granular fractions not preloaded with nonradioactive cystine. The difference, which constitutes cystine counter-transport and confirms a carrier-mediated process (2 I), was expressed as pmol [%]cystine uptake/min/U of hexosaminidase.
One U of hexosaminidase hydrolyzed 1 nmol of 4-methylurnbelliferyl-2-acetamido-2 deoxy-P-D-glucopyranoside substrate per min at 37" C under conditions previously described (4, 5). Cystine was assayed by the cystine binding protein method (22) , and protein was assayed by the method of Lowry et al. (23) . (Table 1) . Fibroblasts from the patient's father stored above normal amounts of cystine, consistent with published values for individuals heterozygous for infantile nephropathic cystinosis (16). Despite this mild increase in endogenous cystine content, the velocity of cystine egress was entirely normal (Table 1) .
Patient 2 was considered to have benign or adult cystinosis. His endogenous polymorphonuclear leucocyte cystine content (2.85 nmol % cystine/mg protein) ( Table 2 ) was lower than reported for infantile nephropathic cystinosis, 4 to 14 nmol 112 cystine/mg protein (16). When tested on two separate occasions, leucocyte granular fractions from this patient displayed 9 and 29% of the normal amount of cystine countertransport (Table  2) , well above the range for nephropathic cystinosis (0-5% of Table I . Cystine egress fiom Jibroblast granular fiactic normal). This indicated a substantial but not complete deficiency of lysosomal cystine carrier function in patient 2. The patient's parents each exhibited elevated endogenous leucocyte cystine values and reduced lysosomal cystine counter-transport (Table  2) . However, both the father and the mother had more than the average expected 50% of normal carrier function (24) , i.e. approximately 67 and 68%, respectively.
Cystine egress from the patient's leucocyte lysosomes was negligible, with no decrement in granular fraction cystine after 40 min (data not shown).
DISCUSSION
Patients with classical nephropathic (infantile) cystinosis have renal tubular Fanconi syndrome at 6 to 18 months of age, with renal failure requiring transplantation by 10 yr of age. Growth retardation, hypophosphatemic rickets, chronic acidosis, and acute dehydration accompany the Fanconi syndrome. A retinopathy characterized by depigmented retinal epithelium is usually present at the time of diagnosis, and photophobia progresses in severity. Among Caucasians, skin pigmentation is noticeably decreased. Cystine crystals are abundant within the kidney, bone marrow, cornea, conjunctiva, intestine, liver, macrophage, and lymph node cells (1-3).
Intermediate (adolescent) cystinosis is diagnosed between 18 months and 17 yr of age and represents a milder disorder than infantile cystinosis (8-12). Renal glomerular dysfunction clearly occurs, but with decreased severity and a slower rate of progression. Tubular reabsorption deficits do not appear as early or as complete as in infantile cystinosis, but even the original adolescent cystinosis patient described by Goldman et al. (8) had polyuria in infancy. Growth retardation, decreased skin pigmentation, retinopathy, and photophobia are variable in appearance. Typical cystine crystals are observed in the cornea, conjunctiva, bone marrow, and, when sought for, in the kidney (1 I).
Ophthalmologists generally diagnose benign (adult) cystinosis on the basis of corneal crystals noted incidentally on examination (1 3-18 ). These patients have no renal disease or retinopathy and exhibit normal growth and skin pigmentation. Cystine crystals appear in the cornea, bone marrow, and certain leucocytes, but not in the kidney (1 3, 15, 18 ). It may be dificult to distinguish benign from intermediate cystinosis on clinical grounds early in life. Two patients (including patient 1 described herein) were ' diagnosed as having benign cystinosis at ages 7 and 5 yr based on their entirely normal renal function and growth. However, by ages 15 and 14 yr, the patients were uremic and required renal transplantation ( 12).
What biochemical findings distinguish the three established types of cystinosis? Compared with nephropathic cystinosis fi- (Table 1) . It was possible, based on the different clinical manifestations, that the variant forms of cystinosis might result from a defect different from the well-recognized lysosomal cystine transport deficiency of infantile nephropathic cystinosis (4-7). We have now shown that, at least for two typical variant cystinosis patients, lysosomal cystine transport is defective (Tables 1 and 2) , mitigating against the possibility that some process of lysosomal cystine catabolism is impaired in these variants.
When the velocity of cystine egress from leucocyte granular fractions was measured, cells of the benign variant resembled nephropathic cystinosis cells in showing virtually no loss of cystine. However, when the method of cystine counter-transport was employed, the benign cystinosis patient showed a significant residual cystine transport capacity (Table 2 ). This finding is --consistentwith the relatively low level of cystin'e storage in benign cystinosis. Parental values of cystine counter-transport, over 60% of normal, were also consistent with the presence of residual cystine carrying capacity in the patient, and support the autosoma1 recessive nature of inheritance originally proposed for benign cystinosis ( 15).
Recently, somatic cell fusion experiments have shown that benign and nephropathic cystinosis cells do not complement each other (25) , suggesting that their mutations are allelic. While this may not hold for all combinations of benign and nephropathic cells, it supports our finding of decreased but measurable lysosomal cystine transport in benign cystinosis (Table 2) , and asymptomatic except for the occasional patient with photophobia (15). Intermediate in severity between these two extremes are adolescent cystinosis patients, whose slight reduction in cystine storage compared with infantile cystinosis patients suggests that they have a certain amount (perhaps not measurable) of residual lysosomal cystine carrying capacity. For these the enormous variabilitv in clinical course relates to the degree of residual activity combined with the differential susceptibifty of tissues to cystine storage. It may even be that one individual, or one particular cell type, relies more on lysosomal proteolysis than another and, therefore, accumulates intralysosomal cystine more rapidly. Future determination of the molecular lesions in nephropathic, intermediate, and benign cystinosis will help confirm or deny this proposed explanation for the different clinical manifestation in these variants. 
